Standard BioTools Operating Income 2010-2025 | LAB
Standard BioTools operating income from 2010 to 2025. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
| Standard BioTools Annual Operating Income (Millions of US $) |
|
|---|---|
| 2024 | $-175 |
| 2023 | $-77 |
| 2022 | $-116 |
| 2021 | $-67 |
| 2020 | $-51 |
| 2019 | $-52 |
| 2018 | $-48 |
| 2017 | $-58 |
| 2016 | $-73 |
| 2015 | $-50 |
| 2014 | $-52 |
| 2013 | $-19 |
| 2012 | $-18 |
| 2011 | $-19 |
| 2010 | $-15 |
| 2009 | $-18 |
| Standard BioTools Quarterly Operating Income (Millions of US $) |
|
|---|---|
| 2025-06-30 | $-26 |
| 2025-03-31 | $-33 |
| 2024-12-31 | $-53 |
| 2024-09-30 | $-32 |
| 2024-06-30 | $-30 |
| 2024-03-31 | $-60 |
| 2023-12-31 | $-21 |
| 2023-09-30 | $-21 |
| 2023-06-30 | $-17 |
| 2023-03-31 | $-17 |
| 2022-12-31 | $-21 |
| 2022-09-30 | $-29 |
| 2022-06-30 | $-39 |
| 2022-03-31 | $-28 |
| 2021-12-31 | $-11 |
| 2021-09-30 | $-20 |
| 2021-06-30 | $-17 |
| 2021-03-31 | $-19 |
| 2020-12-31 | $-17 |
| 2020-09-30 | $-5 |
| 2020-06-30 | $-14 |
| 2020-03-31 | $-15 |
| 2019-12-31 | $-9 |
| 2019-09-30 | $-14 |
| 2019-06-30 | $-15 |
| 2019-03-31 | $-14 |
| 2018-12-31 | $-11 |
| 2018-09-30 | $-12 |
| 2018-06-30 | $-13 |
| 2018-03-31 | $-13 |
| 2017-12-31 | $-9 |
| 2017-09-30 | $-16 |
| 2017-06-30 | $-16 |
| 2017-03-31 | $-18 |
| 2016-12-31 | $-18 |
| 2016-09-30 | $-18 |
| 2016-06-30 | $-18 |
| 2016-03-31 | $-19 |
| 2015-12-31 | $-14 |
| 2015-09-30 | $-8 |
| 2015-06-30 | $-15 |
| 2015-03-31 | $-14 |
| 2014-12-31 | $-10 |
| 2014-09-30 | $-13 |
| 2014-06-30 | $-12 |
| 2014-03-31 | $-17 |
| 2013-12-31 | $-5 |
| 2013-09-30 | $-5 |
| 2013-06-30 | $-4 |
| 2013-03-31 | $-5 |
| 2012-12-31 | $-3 |
| 2012-09-30 | $-4 |
| 2012-06-30 | $-4 |
| 2012-03-31 | $-6 |
| 2011-12-31 | $-3 |
| 2011-09-30 | $-4 |
| 2011-06-30 | $-7 |
| 2011-03-31 | $-5 |
| 2010-12-31 | $-2 |
| 2010-09-30 | $-3 |
| 2010-06-30 | $-4 |
| 2010-03-31 | $-5 |
| 2009-09-30 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.474B | $0.174B |
| Standard BioTools Inc. is a solution provider in health and disease using its proprietary mass cytometry and microfluidics technologies. It serves academic, government, pharmaceutical, biotechnology, plant and animal research and clinical laboratories. Standard BioTools Inc., formerly known as Fluidigm Corporation, is based in SOUTH SAN FRANCISCO, Calif. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $46.602B | 59.29 |
| Tempus AI (TEM) | United States | $13.186B | 0.00 |
| Doximity (DOCS) | United States | $12.437B | 55.33 |
| Hims & Hers Health (HIMS) | United States | $9.717B | 79.61 |
| IRhythm Technologies (IRTC) | United States | $5.323B | 0.00 |
| Hinge Health (HNGE) | United States | $4.319B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $2.748B | 40.40 |
| Privia Health (PRVA) | United States | $2.626B | 194.54 |
| Heartflow (HTFL) | $2.422B | 0.00 | |
| Phreesia (PHR) | United States | $1.808B | 0.00 |
| Enovis (ENOV) | United States | $1.771B | 9.36 |
| 10x Genomics (TXG) | United States | $1.752B | 0.00 |
| Omnicell (OMCL) | United States | $1.520B | 29.28 |
| Schrodinger (SDGR) | United States | $1.438B | 0.00 |
| Azenta (AZTA) | United States | $1.410B | 61.52 |
| Clover Health Investments (CLOV) | United States | $1.356B | 0.00 |
| Claritev (CTEV) | United States | $1.180B | 0.00 |
| Evolent Health (EVH) | United States | $1.140B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.659B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.570B | 0.00 |
| Veradigm (MDRX) | United States | $0.525B | 0.00 |
| Talkspace (TALK) | United States | $0.445B | 132.75 |
| Butterfly Network (BFLY) | United States | $0.390B | 0.00 |
| Carlsmed (CARL) | United States | $0.380B | 0.00 |
| TruBridge (TBRG) | United States | $0.298B | 52.29 |
| Outset Medical (OM) | United States | $0.244B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.235B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.233B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.220B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.194B | 0.00 |
| CapsoVision (CV) | United States | $0.187B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.167B | 0.00 |
| CareCloud (CCLD) | United States | $0.135B | 6.12 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.127B | 0.00 |
| American Well (AMWL) | United States | $0.113B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.099B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.071B | 0.00 |
| Pulmonx (LUNG) | United States | $0.068B | 0.00 |
| 111 (YI) | China | $0.061B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.053B | 0.00 |
| HeartBeam (BEAT) | United States | $0.038B | 0.00 |
| Zhongchao (ZCMD) | China | $0.026B | 0.00 |
| Precipio (PRPO) | United States | $0.023B | 0.00 |
| PROFUSA (PFSA) | United States | $0.016B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.016B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.012B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.010B | 0.00 |
| HeartSciences (HSCS) | United States | $0.008B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.007B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.006B | 0.00 |
| Movano (MOVE) | United States | $0.005B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.005B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |